Test AMAS (AntiMalignin Antibody Screen)

AMAS blood testing can be useful for the early detection of cancer. In breast cancer, the test can detect the presence of cancerous cells up to 18 months before more conventional detection methods. This is an FDA approved test which has proved useful in early detection and monitoring treatment. The test results should return to normal within 3 months after successful treatment for cancer, otherwise cancerous cells remain. The test will not tell you where the cancer is located, just whether it is present or not. Additional information is available from Oncolab, located in Boston, Massachusetts and other Internet sources.

 


Test AMAS (AntiMalignin Antibody Screen) can help with the following

Risks  


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


Tumors, Malignant  


Key

May do some good
Likely to help

Glossary

Cancer

Refers to the various types of malignant neoplasms that contain cells growing out of control and invading adjacent tissues, which may metastasize to distant tissues.

FDA

The (American) Food and Drug Administration. It is the official government agency that is responsible for ensuring that what we put into our bodies - particularly food and drugs - is safe and effective.

Leave a Reply

Your email address will not be published. Required fields are marked *